Pregnancy and substance dependency;Schwangerschaft und Substanzabhängigkeit

Gesundheitswesen

Volumn 63, Issue SPEC. ISS. 2, 2001, Pages

  Kraigher, D ^a   Schindler, S ^a   Ortner, R ^a   Fischer, G ^a  

^a MEDICAL UNIVERSITY OF VIENNA   (Austria)

Author keywords

Maintenance Therapy; Pregnancy; Substance Abuse

Indexed keywords

STREET DRUG;

ADDICTION; ALCOHOLISM; ARTICLE; CONGENITAL MALFORMATION; FEMALE; FETAL ALCOHOL SYNDROME; GERMANY; HUMAN; NEWBORN; OPIATE ADDICTION; PATIENT CARE; PREGNANCY; PREGNANCY COMPLICATION;

ABNORMALITIES, DRUG-INDUCED; ALCOHOLISM; FEMALE; FETAL ALCOHOL SYNDROME; GERMANY; HUMANS; INFANT, NEWBORN; OPIOID-RELATED DISORDERS; PATIENT CARE TEAM; PREGNANCY; PREGNANCY COMPLICATIONS; STREET DRUGS; SUBSTANCE-RELATED DISORDERS;

EID: 0035434308     PISSN: 09413790     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (27)

1. Leshner Al. Addiction is a brain disease, and it matters. Science 1997; 278: 25-47
2. Jarvis MAE, Schnoll SH. Methadone using during pregnancy. NIDA research monograph 1995; 149: 58-77
3. Finnegan LP. Addiction and pregnancy: Maternal and child issues. In: Tagliamonte A, Maremani I (Hrsg). Drug related clinical problems. Wien: Springer, 1995: 137-147
4. Longo LD. The biological effects of carbon monoxid on the pregnant woman, fetus and new born infant. Am J Obstet Gynecol 1977; 129: 44-51
5. Fingerhut LA, Kleinmann JC, Kendrick JS. Smoking before, during and after pregnancy. Am J Public Health 1990; 80: 541-544
6. Windsor RA, Boyd NR, Orleans CT. A meta evaluation of smoking cessation intervention research among pregnant women: Improving the science and art. Health Education Research 1998; 13: 419-438 (3)
7. Smit DW.The fetal Alcohol syndrom. Hosp Pract 1979; 14: 121
8. Kandall SR, Doberczak TM, Mauer KR, Strashun RH, Korts DC. Opiate vs CNS depressant therapy in neonatal drug abstinence syndrome. Am J Dis Child 1983; 137: 378-382
9. Handler A, Kistin N, Davis F. Cocaine use during pregancy: Perinatal outcomes. Am J Epidemiol 1991; 133: 818-825
10. Oro AS, Dixon SD. Perinatal cocaine and methamphetamine exposure and neonatal correlates. J Pediatr 1987; 111: 571
11. Brown E, Zuckerman B. The infant of the drug abusing mother. Pediatr Ann 1991; 20: 555-563
12. Fischer G, Jagsch R, Eder H, Lenkh C, Habeier A, Aschauer HN, Kasper S. Maintenance therapy with synthetic opioids within a multidisziplinary program - a stabilising necessity for pregnant opioid dependent females. Arch Women Ment Health 1989; 1: 109-116
13. Harper RG, Feingold E, Gersten-Woolf NB, Sokal MM. Maternal ingested methadone, dody fluid methadone and the neonatal withdrawal syndrome. Am Jobstset Gynecol 1977; 129: 417-424
14. Pond SM, Kreek Mj, Tong TG, Raghunat J, Bennowitz NL Altered methadone pharmacokinetics in methadone-maintained pregnant women. J pharm Exp Ther 1985; 233: 1-61
15. Dole VP, Nyswander M. A medical treatment for diacetyl (heroin) addiction. JAMA 1965; 193: 80-84
16. Ball JC, Ross A. The effectivness of methadone maintenance treatment. New York: Springer, 1991
17. Levy M, Spino M. Neonatal withdrawal syndrome: Associated drugs and pharmacological mangment. Pharmacother 1993; 13: 202-211
18. Doberczak TM, Kandall SR, Friedmann P. Relationship between maternal methadone dosage maternal-neonatal methadone levels, and neonatal withdrawal. Obstet Gynecol 1993; 81: 936-940
19. Fischer G, Presslich O, Diamant K, Schneider C, Pezawas L, Kasper S. Oral morphine sulfate in the treatment of opiate dependent patients. Alcoholism 1996; 32: 35-43
20. Fischer G, Jagsch R, Eder H, Gombas W, Etzersdorfer P, Schmidl-Mohl K, Schatten C, Weninger M, Aschauer HN. Comparison of methadone and slow-release morphine maintenance in pregnant addicts. Addiction 1999; 94: 231-239 (2)
21. Jasinski DR, Pevnik JS, Griffith JD. Human pharmacology and abuse potential of buprenorphine. Arch of Gen Psychiatry 1978; 35: 501-516
22. Cowan A, Doxey JC, Harry EJR. The animal pharmacology of buprenorphine: An oripavine analgesic agent. British Journal of Pharmacology 1977; 60: 547-554
23. Lange WR, Fudala PJ, Dax EM, Johnson RE. Safety and side eefects of buprenorphine in the clinical management of heroin addiction. Drug and Alcohol Dependence 1990; 26: 19-28
24. Fischer G, Rolley E, Johnson RE, Eder H, Jagsch R, Peternell A, Weninger M, Langer M, Aschauer HN. Treatment of pregnant women with buprenorphine. Addiction: 2000; 95 (2): 239-244
25. Blinick G, Jerez E, Wallach RE. Methadone maintenance, pregnancy and progeny. JAMA 1973; 225: 477-479
26. Finnegan LP, Kaltenbach K. Neonatal abstinence syndrom, pharmacotherapy and developmental outcome. Neurobehav toxicol teratol 1986; 8: 353-355
27. Theis JG. Selby P, Ikizler J, Koren G. Current managment of the neonatal abstinence syndrom: A critical analysis of the evidence. Biol of the neonate 1977; 71: 345-356